Deprenyl in Tourette’s Syndrome and ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-10-5-14

Deprenyl in Tourette’s Syndrome and ADHD

Pediatric Neurology Briefs

Volume 10 (1996): Issue 5

By: J Gordon Millichap

Open Access

|May 1996

Abstract

The efficacy of deprenyl, a monoamine oxidase inhibitor, was evaluated in the treatment of ADHD in 24 children and adolescents with comorbid Tourette’s syndrome (TS) enrolled at the University of Rochester and Baylor College of Medicine.

References

Feigin A Kurlan R McDermott MP Beach J Dimitsopulos T Brower CA A controlled trial of deprenyl in children with Tourette’s syndrome and attention deficit hyperactivity disorder Neurology 1996 Apr 46 4 965 8 10.1212/WNL.46.4.965 8780073
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-10-5-14 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 40 - 40

Published on: May 1, 1996

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Monoamine Oxidase,

Tourette’s Syndrome,

ADHD Symptoms

© 1996 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 10 (1996): Issue 5